SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as investors weigh strong Q1 earnings results, including improved free cash flow and user growth, against cautious guidance and the termination of a partnership. The community is actively debating the effectiveness of leadership and debating the potential for a long-term turnaround driven by cost-cutting initiatives and future hardware developments.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is generating significant market buzz ahead of its quarterly earnings release as investors weigh the company's aggressive pivot toward the data center CPU market against its high valuation. The community remains sharply divided, with bulls pointing to robust demand for AI-driven compute as a long-term catalyst, while bears argue that supply chain constraints and the recent vertical price rally suggest a bubble-like environment susceptible to a post-earnings selloff.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is gaining market attention as shareholders of Warner Bros. Discovery prepare for an upcoming pivotal vote on their proposed $110 billion merger. Community sentiment remains split, with some traders optimistic about the consolidation's long-term synergy potential while others voice frustration over price volatility and the broader implications of the deal's structure.

Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.

Root Inc - Ordinary Shares - Class A

Root Inc

Root Inc. is trending as investors react to a significant milestone where the company surpassed 200,000 policies through its partnership with Carvana, triggering the exercisability of warrants. Community discussion remains heavily polarized between bulls betting on rapid partnership-led growth and share buybacks, and bears highlighting persistent management insider selling, executive compensation concerns, and questions regarding the long-term sustainability of the current growth model.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry shares are trending as investors rally around the companys pivot to a software-driven growth model, fueled by its QNX platform's critical role in physical AI, robotics, and automotive systems. The community is actively discussing strong quarterly earnings and the strategic integration of QNX software with Nvidias platforms as major indicators of long-term revaluation potential.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is trending as the community closely monitors its recent $625 million acquisition of Mirantis and anticipates upcoming earnings, fueling debates over the company's shift toward a full-stack AI cloud model. Investors are actively discussing the potential for major hyperscaler contract announcements and whether this move effectively bridges the gap in their AI software capabilities.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing strong momentum as investors weigh a potential buyout against the company's scaling revenue and upcoming clinical catalysts. The community is actively discussing the strong adoption of BRIUMVI and anticipation surrounding the subcutaneous formulation trial results, which many view as a critical inflection point for the stock.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is currently in focus as investors analyze the stock's sharp volatility following a contentious short-seller report and the company's subsequent rebuttal. The community is actively debating the stock's fundamental valuation, with many traders weighing the impact of share repurchases, recent regulatory developments, and potential earnings performance against the backdrop of competitive headwinds.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is trending following an earnings beat that exceeded profit expectations and reaffirmed revenue guidance, sparking significant buying interest from the community. Investors are closely tracking the company's path to profitability and margin expansion, with many debating whether the current momentum marks the start of a sustained reversal.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is surging on investor enthusiasm as the market re-rates the company from a hardware vendor to a backlog-backed energy storage play critical for AI data center infrastructure. The community is actively debating the durability of this momentum, contrasting record-setting contracted order backlogs and hyperscaler supply agreements against previous concerns over margin execution and short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tilray Brands (NASDAQ:TLRY) Stock Price Up 1.2% - Time to Buy?

Tilray Brands (NASDAQ:TLRY) Stock Price Up 1.2% - Should You Buy...

Should SNDL Stock Be in Your Portfolio Post Q1 Earnings?

SNDL faces pressure after Q1 results show falling sales, weak cannabis demand, and margin strain, raising concerns about growth in a saturated Canadian market.

<ul class="summary-bullets"><li>BrewDog, now owned by Tilray, announced a 12-month partnership covering major U.K. festivals.</li><li>Tilray has recently rolled out several beverage-focused announcements, including new ready-to-drink products from 10 Barrel Brewing.</li><li>Investor frustration comes despite improving U.S. cannabis policy momentum after marijuana was moved from Schedule I to Schedule III for regulated medical use last month.</li></ul>Shares of Tilray Brands, Inc. (TLRY) slid to an over nine-month low on Tuesday after another beer-focused announcement fueled retail concerns that the company is becoming more of a brewery than a cannabis player.<a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> fell 4% on Tuesday to $5.69, logging its third straight session of losses. It is also the second-worst performer so far this year among major cannabis stocks, with shares down 37%.&nbsp;<h2 class="st-heading-2">Beer Buzz, Cannabis Blues</h2>The latest pressure came after BrewDog, now owned by Tilray, announced a 12-month partnership with Underbelly covering major U.K. festivals and venues, including the Edinburgh Fringe Festival, London’s Underbelly Boulevard Soho and holiday events in Trafalgar Square and Leicester Square.The announcement added to a string of beverage-focused headlines from Tilray over the past few weeks. Earlier this month, Tilray-owned 10 Barrel Brewing launched new ready-to-drink beverages called “Clean Slate” and “Salty Sips,” while SweetWater Brewing unveiled a new “Livin’ Salty” lager collaboration with Salt Life.The flow of brewery, beer and beverage announcements has frustrated cannabis-focused investors, particularly after the U.S. government moved marijuana from Schedule I to Schedule III for regulated medical use last month. The policy change was widely viewed as one of the most important federal cannabis reforms in decades and sparked optimism across pot stocks.<h2 class="st-heading-2">Tilray's US Pot Push Still On Hold</h2>After the U.S. rescheduling announcement, Tilray aggressively positioned itself as a major player in the cannabis market. CEO Irwin Simon said at the time that “federal policy is finally aligning with science, medicine, and most importantly, patient needs,” while calling the policy change a “defining inflection point” for medical cannabis in the U.S.In a later Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/watch?v=fn5xb8RPLPM">interview</a>, Simon said Tilray was “one of the largest cannabis companies in the world” with over 7 million square feet of cultivation capacity and cannabis operations spanning more than 21 countries.However, Simon also acknowledged that Tilray currently has no U.S. cannabis operations involving THC, the compound in marijuana responsible for the “high” associated with cannabis use. “Tilray today cannot sell any cannabis in the U.S.,” he said, adding that the company instead chose “a different fork in the road” by expanding into beer, beverages and wellness businesses while waiting for federal cannabis reform.Simon said Tilray has already developed the “playbook,” genetics and medical research to move quickly into the U.S. cannabis market if regulations advance further. “Could we be in a business within six months? Absolutely, if we get the right approvals,” he said.<h2 class="st-heading-2">Tilray Says It’s ‘Not A Little Craft Brewer’</h2>Tilray’s beverage focus accelerated after the company completed its acquisition of key BrewDog assets in March, including the global brand, U.K. brewing operations, and brewpub portfolio. Tilray said the deal would help build a global beverage platform generating $500 million in annual revenue.During the company’s most recent earnings call, Simon stressed the importance of BrewDog and the broader beverage business. “I've done over 100 acquisitions in my life, and I've never received more calls, congratulations, and a brand with more awareness on a global basis, which helps Tilray to be at the forefront around the world,” Simon said while discussing BrewDog.He also said Tilray is “not just a little craft brewer anymore” as the company scales toward nearly 18 million beer cases globally. The company said that, after the BrewDog transaction, Tilray is now the fourth-largest craft brewer in the U.S. and the top craft brewer in the U.K. Simon said Tilray is evolving into a “global lifestyle consumer products company” spanning beverages, cannabis and wellness products across over 20 countries.<h2 class="st-heading-2">How Do Retail Traders Feel About TLRY?</h2>On Stocktwits, retail sentiment for TLRY hovered around record low levels (21/100) at ‘extremely bullish’ levels amid nearly a 600% surge in 24-hour message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/tlry_ss_png_7d1d173bf2.webp" alt="tlry ss.png" width="966" height="146"><figcaption>TLRY sentiment and message volume as of May 6 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Alexsolstice/message/652324536">said</a> TLRY “completely missed to prepare for US rescheduling opportunities - no US licensed assets, no net cash. Mostly dilution and lawsuits.”&nbsp;<stembedurl>https://stocktwits.com/Alexsolstice/message/652324536</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/smooth2222/message/652300863">said</a>, “PR your Cannabis plans, stop with the beverage PR’s,” while a separate trader&nbsp;<a href="https://stocktwits.com/knocker/message/652229091">said</a>, “ individuals are holding a stock that was marketed as a 'Quantum Leap' for cannabis but has settled into being a German Pill Distributor that owns a Mid-Tier Craft Brewery conglomerate.”<stembedurl>https://stocktwits.com/knocker/message/652229091</stembedurl>TLRY stock has risen 29% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/amc-stock-soars-on-record-post-pandemic-box-office-outlook/cZQyr18ReaE">AMC Stock Soars On Box Office Comeback: CEO Bullish On ‘Record Post-Pandemic’ Year&nbsp;</a>

In this photo illustration, the logo of a Canadian pharmaceutical and cannabis company, Tilray, is seen on a smartphone and a PC screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Tilray Stock's High Is Fading — Cannabis Bulls Aren't Buzzing Over The Beer Pivot

CEO Irwin Simon said that the company currently has no U.S. THC cannabis operations and chose “a different fork in the road” by expanding into beverages.

Equity

Tilray Brands (NASDAQ:TLRY)  Shares Down 3.6%   - Here's Why

Tilray Brands (NASDAQ:TLRY) Trading Down 3.6% - Here's What Happened...

Cannabis Stocks To Watch Now - May 5th

Tilray Brands, Akanda, and Canopy Growth are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of publicly traded companies that participate in the cannabis industry, including cultivators, processors, distributors, retailers, and an...

Tilray Brands (NASDAQ:TLRY) Stock Price Down 4.2%  - Should You Sell?

Tilray Brands (NASDAQ:TLRY) Trading Down 4.2% - Should You Sell...

Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime Soon

Key PointsTilray Brands believes it's in a great position to take advantage of opportunities in a regulated medical marijuana market in the U.S...

Tilray Brands (NASDAQ:TLRY) Stock Price Down 1.3% - Here's Why

Tilray Brands (NASDAQ:TLRY) Shares Down 1.3% - Here's Why...

Tilray Brands (NASDAQ:TLRY) Stock Price Up 1.6% - What's Next?

Tilray Brands (NASDAQ:TLRY) Trading 1.6% Higher - Here's What Happened...

<ul class="summary-bullets"><li>Since the marijuana reclassification move, AKAN stock has significantly outperformed peers Tilray, Canopy Growth, and Aurora Cannabis.</li><li>The regulatory shift on marijuana is expected to provide tax relief for licensed operators and support research.</li><li>AKAN stock is set to test the 200-DMA for the first time since October 2025.</li></ul>Shares of Akanda Corp (AKAN) are once again on a tear, surging 32% in pre-market trading on Thursday, yet even that sharp move would rank only as its fourth-biggest single-day gain this year if it holds at close.The latest pre-market jump extends a powerful two-day rally that has sent AKAN shares soaring about 114%, putting the stock on track to test its 200-day moving average for the first time since Oct. 1, 2025.<a href="https://stocktwits.com/symbol/AKAN">AKAN shares</a> recorded their best-ever single-day gains after news of marijuana reclassification broke earlier this month.&nbsp;The stock has rallied nearly 700% in the six sessions since then through Wednesday’s close.<h2 class="st-heading-2">What Triggered The Breakout Rally?</h2>The U.S. Department of Justice moved to <a href="https://stocktwits.com/news-articles/markets/equity/tlry-cgc-acb-msos-pare-early-gains-after-marijuana-reclassification-retail-says-weed-industry-is-reborn/cZBfz1nReRK">reclassify</a> medical marijuana as a less dangerous drug, following an executive order from President Donald Trump. The change moves it from Schedule I to Schedule III under the Controlled Substances Act.While the change does not legalize marijuana, it is expected to ease regulations, provide tax relief for licensed operators, and support research. Officials said the update will also speed up rulemaking, expand access to medical treatments, and strengthen oversight of medical marijuana programs across the U.S.<h2 class="st-heading-2">What Are Retail Traders Saying?</h2>AKAN shares have been under the spotlight for a while, with message volumes on Stocktwits exceeding a massive 106,200% over a 30-day period. Retail sentiment has remained in the ‘extremely bullish’ territory over the time period.One user expects the stock to climb to triple digits. It is currently trading at $35.<stembedurl>https://stocktwits.com/momoneyinfla/message/651829518</stembedurl>Another user said the movement doesn’t seem like a “pump and dump” scheme.<stembedurl>https://stocktwits.com/Wowsuchboolish/message/651836014</stembedurl>Since the marijuana reclassification move, AKAN stock has significantly outperformed Tilray (TLRY), which has lost around 8%, Canopy Growth (CGC), down around 4%, and Aurora Cannabis (ACB), also down around 8%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

AKAN Stock Surges 32% Pre-Market – But Still Trails Its Largest Single-Day Rally This Year

The DOJ reclassified marijuana from a Schedule I to a Schedule III drug last week.

This Cannabis Stock’s 700% Run In A Week Has Retail Traders Eyeing Triple Digits

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Stocktwits

Stocktwits Polls

Shareholders are aggressively calling for the removal of Irwin Simon due to dilution, perceived corruption, and poor strategic leadership.

Persistent debate surrounds the possibility of the share price returning to double digits following potential policy catalysts.

Traders are betting on a massive short squeeze driven by oversold conditions and potential federal regulatory news.

The company's focus on diversifying into THC-infused drinks and beer assets remains a divisive topic among investors.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.01	--	--	N/A
Q3 '25	-$0.14	-$0.22	-64.79%	MISSED
Q2 '25	-$0.21	-$0.41	-91.89%	MISSED
Q1 '25	-$0.03	$0.00	100.00%	BEAT
Q4 '24	-$0.02	-$1.30	-5431.92%	MISSED

TLRY
Tilray Brands Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest TLRY News

TLRYTilray Brands Inc